ASEAN Medical Device Directive (AMDD)
The ASEAN Medical Device Directive is the regional agreement supporting convergence of medical device regulation among ASEAN member states. It establishes shared principles while leaving registration and enforcement to national authorities.
What is the ASEAN Medical Device Directive?
The ASEAN Medical Device Directive, commonly called AMDD, is an agreement among ASEAN member states to harmonize core medical device regulatory principles and reduce unnecessary technical barriers to trade.
The official ASEAN agreement states that the agreement was signed on November 21, 2014 and entered into force on January 1, 2015.
What does the AMDD harmonize?
AMDD establishes shared concepts for matters such as medical device definitions, risk classification, essential principles of safety and performance, conformity assessment, registration information and post-market responsibilities.
It also includes the ASEAN Common Submission Dossier Template. These common elements make it easier to prepare a reusable regulatory evidence core for multiple ASEAN markets.
Does AMDD create one ASEAN medical device approval?
No. There is no single ASEAN medical device regulator, application portal or marketing authorization covering all member states.
Manufacturers still apply to each national regulator and comply with local law. Approval in Singapore, for example, does not automatically authorize the device in Malaysia, Thailand or Indonesia.
How does AMDD relate to the ASEAN CSDT?
The ASEAN CSDT is the common dossier structure supporting AMDD implementation. It allows manufacturers to organize technical evidence consistently, but member states can require local forms, declarations, certificates and administrative information.
CSDT should therefore be managed as a reusable dossier core with controlled national adaptations rather than as one finished filing for the entire region.
What still varies between ASEAN markets?
National differences can include device grouping, registration pathways, reference-market reliance, local representative and licence-holder roles, labeling, language, fees, review timelines, establishment licensing and post-market reporting.
Manufacturers need a country-by-country strategy for Vietnam, the Philippines and other target markets. Pure Global’s ASEAN MedTech market report provides additional regional context, while each market page addresses its own regulatory pathway.
Market · Jul 24, 2026HSA Singapore Medical Device RegistrationMarket · Jul 24, 2026MDA Malaysia Medical Device RegistrationMarket · Jul 24, 2026MOH Indonesia Medical Device RegistrationResearch Report · Jul 27, 2026IVD Global Market Access 2026Regulatory Update · Jul 21, 2026Malaysia MDA Online Product ClassificationRegulatory Update · Jul 7, 2026Malaysia MeDC@St Automated Re-Registration 2026Research Report · Jul 6, 2026Continuous Glucose Monitors: The Global Regulatory MapRegulatory Update · Jul 1, 2026Malaysia-China Joint Evaluation Pilot Programme 2026Regulatory Update · Jul 1, 2026Philippines FDA Extends CMDR Fee Suspension 2026Research Report · Jun 29, 2026AI as a Medical Device: The Global Regulatory MapLet's Talk,
Anywhere You Are.
Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.
Contact us